Multimorbidity, polypharmacy, referrals, and adverse drug events: are we doing things well?

被引：152

作者：

Calderon-Larranaga, Amaia ^{[1
]}

Poblador-Plou, Beatriz ^{[1
]}

Gonzalez-Rubio, Francisca ^{[1
]}

Andres Gimeno-Feliu, Luis ^{[1
]}

Maria Abad-Diez, Jose ^{[1
]}

Prados-Torres, Alexandra ^{[1
]}

机构：

[1] Gen Hosp, Hosp Univ Miguel Servet, Zaragoza 50009, Spain

来源：

BRITISH JOURNAL OF GENERAL PRACTICE | 2012年 / 62卷 / 605期

关键词：

D O I：

10.3399/bjgp12X659295

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Multimorbidity is associated with polypharmacy and may increase the risk of adverse drug events, which become more likely as more medical specialities are involved in management

引用

页数：2

共 48 条

[41] Polypharmacy and Elevated Risk of Severe Adverse Events in Older Adults Based on the Korea Institute of Drug Safety and Risk Management-Korea Adverse Event Reporting System Database
Kim, Grace Juyun
Lee, Ji Sung
Jang, Sujung
Lee, Seonghui
Jeon, Seongwoo
Lee, Suehyun
Kim, Ju Han
Lee, Kye Hwa
JOURNAL OF KOREAN MEDICAL SCIENCE, 2024, 39 (28)
[42] Pill-count and the arithmetic of risk: Evidence that polypharmacy is a health status marker rather than a predictive surrogate for the risk of adverse drug events
Haefeli, Walter E.
Meid, Andreas D.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2018, 56 (12) : 572 - 576
[43] Implementation of the new integrated algorithm for diagnosis of drug-resistant tuberculosis in Karnataka State, India: How well are we doing?
Shankar, Uma S.
Kumar, Ajay M., V
Venkateshmurthy, Nikhil Srinivasapura
Nair, Divya
Kingsbury, Reena
Padmesha, R.
Velu, Magesh
Suganthi, P.
Gupta, Joydev
Ahmed, Jameel
Puttaswamy, G.
Hiremath, Somashekarayya
Jaiswal, Ravi K.
Kokkad, Rony Jose
Somashekar, N.
PLOS ONE, 2021, 16 (01):
[44] Polypharmacy in chronic diseases–Reduction of Inappropriate Medication and Adverse drug events in older populations by electronic Decision Support (PRIMA-eDS): study protocol for a randomized controlled trial
Andreas Sönnichsen
Ulrike S. Trampisch
Anja Rieckert
Giuliano Piccoliori
Anna Vögele
Maria Flamm
Tim Johansson
Aneez Esmail
David Reeves
Christin Löffler
Jennifer Höck
Renate Klaassen-Mielke
Hans Joachim Trampisch
Ilkka Kunnamo
Trials, 17
[45] First Do No Harm-Adverse Events, Drug Intolerance, and Hepatotoxicity: How Can We Not Justify Directly Observed Therapy for Treating Tuberculosis?
Seaworth, Barbara J.
Armitige, Lisa Y.
Griffith, David E.
CLINICAL INFECTIOUS DISEASES, 2013, 57 (07) : 1063 - +
[46] Polypharmacy in chronic diseases-Reduction of Inappropriate Medication and Adverse drug events in older populations by electronic Decision Support (PRIMA-eDS): study protocol for a randomized controlled trial
Soennichsen, Andreas
Trampisch, Ulrike S.
Rieckert, Anja
Piccoliori, Giuliano
Voegele, Anna
Flamm, Maria
Johansson, Tim
Esmail, Aneez
Reeves, David
Loeffler, Christin
Hoeck, Jennifer
Klaassen-Mielke, Renate
Trampisch, Hans Joachim
Kunnamo, Ilkka
TRIALS, 2016, 17
[47] How well do patient reports reflect adverse drug reactions reported by rheumatologists? Agreement of physician- and patient-reported adverse events in patients with rheumatoid arthritis observed in the German biologics register
Gaewert, Lotta
Hierse, Franka
Zink, Angela
Strangfeld, Anja
RHEUMATOLOGY, 2011, 50 (01) : 152 - 160
[48] Impact of Multimorbidity on Targeted Synthetic and Biologic Disease-modifying Antirheumatic Drug (ts/bDMARD) Effectiveness in Patients with Rheumatoid Arthritis: A Two Year Follow-up Study from Mexican Adverse Events Registry BIOADAMEX
Rivera Teran, Vijaya
Vega Morales, David
Colunga Pedraza, Iris Jazmin
Sicsik Ayala, Sandra
Castillo Ortiz, Angel Alejandro
Saavedra Salinas, Miguel Angel
Miranda Hernandez, Dafhne
Irazoque Palazuelos, Fedra
Casasola Vargas, Julio Cesar
Munoz Monroy, Omar Eloy
Carrillo Vazquez, Sandra
Merayo Chalico, Javier
Guaracha Basanez, Guillermo
Torres Valdez, Estefania
Valdes Corona, Luis
Pena Ayala, Angelica
Duran Barragan, Sergio
Ramos Sanchez, Azucena
Paz Viscarra, Aleni
Zamora Tehozol, Erick Adrian
Xibille Friedman, Daniel
Torres Ruiz, Jiram
ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 3870 - 3872

← 1 2 3 4 5 →